Danaher Co. (NYSE:DHR) Shares Acquired by E Fund Management Hong Kong Co. Ltd.

E Fund Management Hong Kong Co. Ltd. increased its stake in Danaher Co. (NYSE:DHR) by 55.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 645 shares of the conglomerate’s stock after buying an additional 229 shares during the quarter. E Fund Management Hong Kong Co. Ltd.’s holdings in Danaher were worth $179,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Good Life Advisors LLC acquired a new stake in shares of Danaher in the third quarter valued at about $217,000. Oak Thistle LLC acquired a new stake in shares of Danaher in the second quarter valued at about $363,000. Norden Group LLC acquired a new stake in shares of Danaher in the first quarter valued at about $4,151,000. Duality Advisers LP acquired a new stake in Danaher during the 1st quarter valued at approximately $5,573,000. Finally, Diversified Trust Co grew its stake in Danaher by 75.4% during the 2nd quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock valued at $1,090,000 after purchasing an additional 1,874 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of recent analyst reports. UBS Group lowered their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Raymond James lowered their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Bank of America raised their price objective on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research note on Wednesday, July 24th. Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Finally, Royal Bank of Canada lowered their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Trading Down 0.2 %

Shares of NYSE DHR opened at $242.32 on Thursday. The company has a market cap of $179.48 billion, a price-to-earnings ratio of 41.07, a price-to-earnings-growth ratio of 4.49 and a beta of 0.83. Danaher Co. has a 12-month low of $188.75 and a 12-month high of $281.70. The company has a current ratio of 1.43, a quick ratio of 1.04 and a debt-to-equity ratio of 0.33. The stock’s 50 day simple moving average is $267.83 and its 200 day simple moving average is $260.42.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The business’s revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the business posted $2.02 EPS. Equities research analysts expect that Danaher Co. will post 7.59 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.45%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio is currently 18.31%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.